CR Intrinsic Investors’s Thermo Fisher Scientific TMO Stock Holding History

CR Intrinsic Investors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-165,000	Closed	-$19.8M	–	155
2014 Q1	$19.8M	Buy	165,000 +100,000	+154%	+$11.9M	0.74%	37
2013 Q4	$7.24M	Sell	65,000 -45,000	-41%	-$4.47M	0.31%	111
2013 Q3	$10.1M	Buy	110,000 +70,000	+175%	+$6.33M	0.31%	113
2013 Q2	$3.38M	Buy	+40,000	New	+$3.33M	0.12%	218

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CR Intrinsic Investors's TMO Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Thermo Fisher Scientific (TMO) in Q2 2014, closing a stake of 165,000 shares — an estimated $19.8M sold.

CR Intrinsic Investors first reported a position in TMO in Q2 2013 and held it in 4 quarters. The position peaked at $19.8M in Q1 2014. 911 funds tracked by Wall St. Rank hold TMO as of Q2 2014.

CR Intrinsic Investors reported no remaining Thermo Fisher Scientific position as of Q2 2014 after selling out during the quarter.
CR Intrinsic Investors sold 165,000 Thermo Fisher Scientific shares in Q2 2014, an estimated $19.8M.
CR Intrinsic Investors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 4 quarters.
CR Intrinsic Investors's Thermo Fisher Scientific position peaked at $19.8M in Q1 2014.
911 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.